All In Biotech

Drug Trial Radar · NCT06411275

A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of HTD1801 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Diet and Exercise

Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 113 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

113

Actual

Start

Mar 31, 2022

Primary completion

Jan 17, 2023

Study completion Jan 17, 2023

Sponsor

Sponsor type
Industry
First posted
May 13, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with diet and exercise alone.

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • HTD1801Drug

    HTD1801 administered orally BID as two capsules

  • PlaceboDrug

    Matching placebo administered orally BID as two to four capsules

  • HTD1801Drug

    HTD1801 administered orally BID as four capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change in HbA1cTime frame: 12 Weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Peking University People's Hospital

    Beijing, China

  • The Second Hospital of Jilin University

    Changchun, China

  • The First People's Hospital of Changde City

    Changde, China

  • The Fourth Affiliated Hospital of Harbin Medical University

    Harbin, China

  • Huizhou Municipal Central Hospital

    Huizhou, China

  • Jinan Central Hospital

    Jinan, China

  • Liaocheng People's Hospital

    Liaocheng, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, China

  • Nanjing First Hospital

    Nanjing, China

  • Nanjing Jiangning Hospital

    Nanjing, China

  • Sir Run Run Hospital Nanjing Medical University

    Nanjing, China

  • The First Affiliated Hospital of Nanyang Medical College

    Nanyang, China

  • Yan'an University Affiliated Hospital

    Yanan, China

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.